Novel Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) – including both accelerated or myeloid blast phases of...
17-Sep-2024 1:30 PM EDT
Add to Favorites